OpenVSafe by OpenVAERS
Search V-safe

T2L-18120-05430

2 vaccinations 4 coded responses 25 check-ins 4 free-text entries 3 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
410 / KY
Registered
2020-12-30
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-30
    Registered in v-safe
  2. 2020-12-30
    Dose 1 — Moderna
  3. 2020-12-30
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Vomiting
    Adult check-in
  9. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  10. 2021-01-06
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-13
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-01-20
    Survey response — day 21, dose 1
    MedDRA: Supraventricular tachycardia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Supraventricular Tachycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-20
    Report sent to call center — day 21, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-01-27
    Survey response — day 28, dose 1
    MedDRA: Supraventricular tachycardia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Supraventricular tachycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-27
    Report sent to call center — day 28, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-01-28
    Dose 2 — Moderna
  17. 2021-01-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Respiratory tract congestion — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  19. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-02-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  23. 2021-02-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  24. 2021-02-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-02-19
    Call successful
    Participant prefers to complete VAERS report online
  27. 2021-02-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-03-04
    Survey response — day 35, dose 2
    MedDRA: Supraventricular tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: SVT
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-03-04
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  30. 2021-03-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-03-13
  32. 2021-03-15
  33. 2021-03-15
  34. 2021-05-01
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  35. 2022-01-28
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Moderna
22021-01-28Moderna

Call center

3 call center cases

2 successful · 1 unsuccessful

See the call center timeline

Free text

Release 2 — day 21, dose 1

2021-01-20

Symptoms: Supraventricular Tachycardia

Release 2 — day 28, dose 1

2021-01-27

Symptoms: Supraventricular tachycardia

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): Congestion

Release 5 — day 35, dose 2

2021-03-04

Symptoms: SVT

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDSupraventricular tachycardia ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…